Sabrina Mai Nielsen

Also affiliated with Frederiksberg Hospital, Odense University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis”.

Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis

New England Journal of Medicine(2024)10.1056/nejmoa2400141

N/A

1.0DataRank · unranked

37 citations

Robin Christensen, Inger Mechlenburg, Lone Ramer Mikkelsen, Claus Varnum, Anders Elneff Graversen +11 more

Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta‐epidemiological study

Research Synthesis Methods(2024)10.1002/jrsm.1708

N/A

0.208DataRank · unranked

3 citations

Caroline M. Moos, John P. A. Ioannidis, George Luta, Johannes I. Berg, Sabrina Mai Nielsen +3 more

Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study

Annals of the Rheumatic Diseases(2025)10.1136/ard-2024-226129

N/A

0.165DataRank · unranked

2 citations

Sabrina Mai Nielsen, Esben Malm, Daniel E. Furst, Josef S Smolen, Peter C. Taylor +7 more

Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group

Seminars in Arthritis and Rheumatism(2023)10.1016/j.semarthrit.2023.152288

N/A

0.165DataRank · unranked

2 citations

Lee S. Simon, Marieke Voshaar, Pam Richards, Niti Goel, Vibeke Strand +21 more

Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors

BMJ Open(2021)10.1136/bmjopen-2021-049850

N/A

0.104DataRank · unranked

1 citations

Sabrina Mai Nielsen, Johannes I. Berg, John P. A. Ioannidis, Josef S Smolen, Peter C. Taylor +6 more

Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study

Mayo Clinic Proceedings(2024)10.1016/j.mayocp.2023.12.008

N/A

0DataRank · unranked

6 citations

Gabriela Schmajuk, Jinoos Yazdany, Patricia Katz, Jing Li, Rachael Stovall +12 more

Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group

Seminars in Arthritis and Rheumatism(2021)10.1016/j.semarthrit.2021.11.004

N/A

0DataRank · unranked

4 citations

Robin Christensen, Jasvinder A. Singh, Nicola Dalbeth, Kenneth G. Saag, William J. Taylor +18 more

OP0243 PROTON PUMP INHIBITOR USE IS ASSOCIATED WITH IMPAIRED BONE MINERAL DENSITY BUT NOT BONE MICROARCHITECTURE IN PATIENTS WITH INFLAMMATORY RHEUMATIC AND MUSCULOSKELETAL DISEASES TAKING GLUCOCORTICOIDS

Annals of the Rheumatic Diseases(2023)10.1136/annrheumdis-2023-eular.491

N/A

0DataRank · unranked

0 citations

Gabriela Schmajuk, Jinoos Yazdany, Patricia Katz, J. Li, Robert T. Stovall +12 more

Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

Seminars in Arthritis and Rheumatism(2024)10.1016/j.semarthrit.2024.152381

N/A

0DataRank · unranked

6 citations

Maarten de Wit, Florian Naye, Jennifer L. Barton, Liana Fraenkel, Linda Li +65 more